72f fusion protein vaccine 72f fusion protein vaccine 72f fusion protein vaccine is a candidate tuberculosis vaccine created by statens serum institut (ssi). the 72f fusion protein is composed of the rv0125 and rv1196 proteins derived from mycobacterium tuberculosis. phase i clinical trials were completed in 2005 and phase ii trials are awaited.